Valuation: Alexandria Co. For Pharmaceuticals & Chemical Industries

Market Cap 678.2Cr 13Cr 11Cr 10Cr 9.38Cr 18Cr 1.18TCr 18Cr 123.66Cr 49Cr 631.59Cr 47Cr 46Cr 1.99TCr P/E 2025
5.7x
P/E 2026 12x
Enterprise Value 639.46Cr 12Cr 11Cr 9.75Cr 8.85Cr 17Cr 1.11TCr 17Cr 116.6Cr 46Cr 595.51Cr 45Cr 44Cr 1.88TCr EV / Sales 2025
0.71x
EV / Sales 2026 1.64x
Free-Float
17.74%
Yield 2025
14.1%
Yield 2026 5.63%
1 day+2.01%
1 week+3.14%
Current month-2.55%
1 month-9.31%
3 months+5.67%
6 months+38.47%
Current year+69.47%
1 week 1,313
Extreme 1313
1,369.9
1 month 1,135
Extreme 1135
1,520
Current year 701.66
Extreme 701.66
1,987
1 year 701.66
Extreme 701.66
1,987
3 years 145.05
Extreme 145.05
1,987
5 years 85
Extreme 85
1,987
10 years 50
Extreme 50
1,987
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.01%+3.14%+67.65%+739.61% 13Cr
+4.28%+0.07%+52.75%+138.78% 1,25800Cr
+2.13%+4.27%+51.21%+91.36% 68TCr
+0.68%+1.54%+33.83%+112.47% 52TCr
-0.37%+2.10%+43.13%+68.62% 39TCr
+1.38%+0.27%+72.42%+45.30% 37TCr
+0.36%+1.99%+31.23%+59.93% 31TCr
-0.55%+1.75%+6.66%+38.75% 29TCr
+1.04%-0.05%+45.29%+76.18% 25TCr
+1.46%-0.59%+42.48%+125.82% 21TCr
Average +0.61%+1.25%+44.66%+149.68% 43TCr
Weighted average by Cap. +0.47%+1.18%+45.37%+96.81%

Financials

2025 2026
Net sales 275.05Cr 5.1Cr 4.56Cr 4.19Cr 3.81Cr 7.21Cr 478.46Cr 7.39Cr 50Cr 20Cr 256.15Cr 19Cr 19Cr 806.77Cr 318.25Cr 5.91Cr 5.27Cr 4.85Cr 4.4Cr 8.34Cr 553.61Cr 8.55Cr 58Cr 23Cr 296.38Cr 22Cr 22Cr 933.48Cr
Net income 39Cr 72.59L 64.8L 59.63L 54.12L 1.03Cr 68Cr 1.05Cr 7.13Cr 2.84Cr 36Cr 2.72Cr 2.67Cr 114.74Cr 52Cr 97.39L 86.93L 79.99L 72.6L 1.38Cr 91Cr 1.41Cr 9.57Cr 3.81Cr 49Cr 3.66Cr 3.58Cr 153.93Cr
Net Debt -28Cr -52.28L -46.67L -42.94L -38.97L -73.86L -49Cr -75.7L -5.14Cr -2.05Cr -26Cr -1.96Cr -1.92Cr -83Cr -39Cr -71.89L -64.17L -59.05L -53.59L -1.02Cr -67Cr -1.04Cr -7.06Cr -2.82Cr -36Cr -2.7Cr -2.64Cr -113.63Cr
Projected Income Statement - Annual - Alexandria Co. For Pharmaceuticals & Chemical Industries
Logo Alexandria Co. For Pharmaceuticals & Chemical Industries
Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).
Employees
-
Date Price Change Volume
09/26/09 EGP 1,356.39 +2.01% 4,773
08/26/08 EGP 1,329.70 -0.44% 2,447
05/26/05 EGP 1,335.59 +1.24% 2,883
04/26/04 EGP 1,319.29 +0.25% 4,022
03/26/03 EGP 1,315.98 +0.07% 2,949
  1. Stock Market
  2. Stocks
  3. AXPH Stock